Your cart is currently empty!
FDA Clinical Insights
Dive into the world of clinical strategy with NAMSA’s exclusive video series, “FDA Clinical Insights.” This series brings together FDA experts and industry leaders, including Dorothy Abel, Partner at Abel and Wolf Consulting; Dr. Robert E. Lee, Former Medical Officer at the US Food & Drug Administration (FDA), Center for Devices and Radiologic Health; Dr. Adam E. Saltman, Principal Strategy Consultant, Clinical and Regulatory Services at NAMSA; and Chris Mullin, Director of Global Strategy Services at NAMSA, to share invaluable lessons and insights.
What You’ll Learn:
- Identify Common Pitfalls: Gain an understanding of the frequent mistakes encountered during the FDA approval process for implantable vascular devices and learn how to avoid them.
- Actionable Insights: Explore three real-world studies presented by our expert panelists, offering practical solutions to the challenges of navigating FDA regulations.
- Enhance Regulatory Strategies: Discover effective strategies to streamline your FDA approval process, enhancing your chances of successful market entry.
Designed for professionals specializing in clinical operations for vascular medical devices, this series offers a unique opportunity to learn from seasoned experts. Enhance your regulatory strategies and explore how NAMSA’s clinical research capabilities can support your journey to market success.
Don’t miss this opportunity to gain real-world clinical strategy insights and avoid costly delays in your projects.